Image 3
The liver is the body's largest internal organ — and one of the most blood-dependent in terms of transfusion medicine.
India has one of the world's highest burdens of chronic liver disease. Hepatitis B infects an estimated 40 million Indians (one of the highest HBV prevalences globally). Hepatitis C affects an estimated 6–12 million more. Alcohol-related liver disease is rising. Non-alcoholic fatty liver disease (NAFLD), driven by India's growing obesity and metabolic syndrome burden, is emerging as a significant cause of cirrhosis.
When these conditions progress to advanced liver disease — cirrhosis, liver failure, or liver cancer — the blood transfusion needs become intensive and specific. Liver transplantation, the only definitive treatment for end-stage liver disease, is one of the most blood-demanding surgical procedures in medicine.
The liver plays a central role in haemostasis — the body's ability to control bleeding. It manufactures the majority of clotting factors, including:
When the liver is severely damaged by cirrhosis, Hepatitis B or C, or acute liver failure, clotting factor production falls. The result is coagulopathy — impaired clotting that leads to spontaneous bleeding from the gut, skin, and other sites, and catastrophic haemorrhage during any surgical procedure.
Fresh Frozen Plasma (FFP): Contains all coagulation factors including those the damaged liver cannot produce. FFP transfusion raises factor levels temporarily, correcting coagulopathy before procedures or managing active bleeding.
Platelet transfusions: Cirrhosis also causes thrombocytopenia (low platelets) through two mechanisms — splenic sequestration (the enlarged spleen traps platelets) and reduced thrombopoietin production (the liver makes this hormone too). Patients with platelet counts below 50,000 before procedures need platelet transfusion.
Packed Red Blood Cells (PRBCs): Variceal bleeding — haemorrhage from dilated veins in the oesophagus or stomach, a complication of portal hypertension in cirrhosis — can be massive and life-threatening. Emergency red cell transfusion is central to managing acute variceal haemorrhage.
Cryoprecipitate: For specific factor deficiencies, cryoprecipitate (containing concentrated fibrinogen, Factor VIII, and Von Willebrand factor) may be needed.
India's 40 million Hepatitis B carriers and estimated 12 million Hepatitis C patients represent the upstream cause of a significant portion of the country's cirrhosis and liver failure burden.
Most HBV and HCV carriers progress through decades of silent infection — with no symptoms while the virus silently damages liver tissue. By the time cirrhosis is diagnosed, the liver has typically lost more than 50% of its functional reserve.
Donor screening: Both HBV and HCV are mandatory screening tests for all donated blood in India (five mandatory TTI tests). Blood banks test for HBsAg (Hepatitis B surface antigen) and anti-HCV antibodies on every unit, with NAT testing at advanced blood banks detecting window-period infections.
Patient blood demand: HBV and HCV patients who progress to cirrhosis and eventually need liver transplantation generate the most intensive blood demand of any chronic liver disease pathway.
Liver transplantation surgery — whether cadaveric (from a brain-dead donor) or living-donor (partial liver from a living relative) — is among the most blood-requiring surgical procedures in all of medicine.
A single liver transplant may require 20–40 units of blood components during the procedure — packed red cells, FFP, platelets, cryoprecipitate. For complex re-transplants or patients with advanced coagulopathy, this can be higher.
India performs approximately 2,000–3,000 liver transplants annually at centres including:
Each of these centres maintains large blood bank reserves specifically for transplant support — and their voluntary donor communities are critical to ensuring that blood is available when a transplant case is scheduled.
People often ask whether they can donate blood if they have been treated for liver disease or carry Hepatitis B or C.
Hepatitis B or C history: Blood donors with a history of Hepatitis B or C infection are generally permanently deferred from blood donation in India. This is because:
Elevated liver enzymes (ALT/AST): Donors with moderately elevated liver enzymes are deferred temporarily — the blood bank asks them to return when enzymes have normalised. Mildly elevated enzymes from non-viral causes (fatty liver, medication) may resolve with lifestyle change.
Mild fatty liver (NAFLD) without significant disease: This may not automatically disqualify a donor, depending on the severity and associated health parameters. Disclose your liver health history at screening; the blood bank medical officer will make the assessment.
Cirrhosis or liver failure: Active, significant liver disease is a deferral reason — both because the donor's haemoglobin is likely inadequate and because the physiological stress of donation is contraindicated.
Register on TheBloodApp. India's 40 million Hepatitis B carriers are a significant portion of the population who cannot donate — which makes the voluntary donors who can give all the more important. Liver transplant patients, cirrhotic patients, and those with acute hepatitis-related liver failure all need blood urgently when they are hospitalised. Your donation supports them directly. To find blood banks and donation camps near you across India, call the number listed in the app.
Sources: WHO — Hepatitis B India Burden | PLOS ONE — National Blood Demand Study India | ILBS Delhi | Medanta Liver Transplant Programme | PMC — Coagulopathy Liver Disease | NBTC India — Donor Deferral Guidelines | WHO India Blood Safety 2024 | eRaktKosh MoHFW
Stay informed, stay inspired — your go-to source for everything about blood donation and impact.
Liver disease accounts for enormous blood demand in India — from cirrhosis-related coagulopathy to liver transplant surgery. Here's how voluntary blood donation supports liver patients and who can donate.
O positive (O+) blood can go to any Rh-positive recipient — 97% of the population. India needs approximately 4.4 million units of O+ blood annually. Here's why O+ donors are critically important.
A positive (A+) is India's third most common blood type at 26%. A negative (A–) is among the rarest. Here's why both matter, who they can help, and why A blood type donors are vital to India's supply.
Be a part of the change — donate safely, stay connected, and help someone in need. Download the app today.
Available on
